Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism

Journal of Neuroscience

Volumn 23, Issue 12, 2003, Pages 4850-4857

  Di, Shi ^a   Malcher Lopes, Renato ^b   Halmos, Katalin Cs ^a   Tasker, Jeffrey G ^a,b  

^a Tulane University   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Corticotropin releasing hormone; Endocannabinoid; G protein; Glucocorticoid; Hypothalamus; Membrane receptor; Oxytocin; Parvocellular neuron; Retrograde messenger; Thyrotropin releasing hormone; Vasopressin

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; BOVINE SERUM ALBUMIN; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; HEMOGLOBIN; MEMBRANE RECEPTOR; MESSENGER RNA; MIFEPRISTONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYTOCIN; PROTIRELIN; SPIRONOLACTONE; STAUROSPORINE; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; HYPOTHALAMUS; MALE; NEGATIVE FEEDBACK; NERVE CELL; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PARVOCELLULAR NEURON; PATCH CLAMP; PIPETTE; POSTSYNAPTIC INHIBITION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS; SYNAPTIC INHIBITION; THALAMUS MIDLINE NUCLEUS; TISSUE SLICE;

EID: 0038755185     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-12-04850.2003     Document Type: Article

References (44)

1. Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287-3293.
2. Avanzino GL, Ermirio R, Ruggeri P, Cogo CE (1987) Effects of corticosterone on neurons of reticular formation in rats. Am J Physiol 253:R25-R30.
3. Bains JS, Ferguson AV (1997) Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurones of the rat paraventricular nucleus. J Physiol (Lond) 499:733-746.
4. Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
5. Burlet AJ, Jhanwar-Uniyal M, Chapleur-Chateau M, Burlet CR, Leibowitz SF (1992) Effect of food deprivation and refeeding on the concentration of vasopressin and oxytocin in discrete hypothalamic sites. Pharmacol Biochem Behav 43:897-905.
6. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N (1987) Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43:113-173.
7. de Kloet ER (2000) Stress in the brain. Eur J Pharmacol 405:187-198.
8. Evans SJ, Murray TF, Moore FL (2000) Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J Steroid Biochem Mol Biol 72:209-221.
9. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556.
10. ffrench-Mullen JM (1995) Cortisol inhibition of calcium currents in guinea pig hippocampal CA1 neurons via G-protein-coupled activation of protein kinase C. J Neurosci 15:903-911.
11. Gifford AN, Tang Y, Gatley SJ, Volkow ND, Lan R, Makriyannis A (1997) Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci Lett 238:84-86.
12. Glasgow E, Kusano K, Chin H, Mezey E, Young III WS, Gainer H (1999) Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology 140:5391-5401.
13. Harrison RW, Balasubramanian K, Yeakley J, Fant M, Svec F, Fairfield S (1979) Heterogeneity of AtT-20 cell glucocorticoid binding sites: evidence for a membrane receptor. Adv Exp Med Biol 117:423-440.
14. Herman JP, Prewitt CM, Cullinan WE (1996) Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 10:371-394.
15. Hoffman NW, Tasker JG, Dudek FE (1991) Immunohistochemical differentiation of electrophysiologically defined neuronal populations in the region of the rat hypothalamic paraventricular nucleus. J Comp Neurol 307:405-416.
16. Hua SY, Chen YZ (1989) Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 124:687-691.
17. Huang CC, Lo SW, Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol (Lond) 532:731-748.
18. Kasai M, Yamashita H (1988) Inhibition by cortisol of neurons in the paraventricular nucleus of the hypothalamus in adrenalectomized rats: an in vitro study. Neurosci Lett 91:59-64.
19. Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1-24.
20. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557.
21. Kreitzer AC, Regehr WG (2002) Retrograde signaling by endocannabinoids. Curr Opin Neurobiol 12:324-330.
22. Laugero KD (2001) A new perspective on glucocorticoid feedback: relation to stress, carbohydrate feeding and feeling better. J Neuroendocrinol 13:827-835.
23. Luther JA, Halmos KC, Tasker JG (2000) A slow transient potassium current expressed in a subset of neurosecretory neurons of the hypothalamic paraventricular nucleus. J Neurophysiol 84:1814-1825.
24. Luther JA, Daftary SS, Boudaba C, Gould GC, Halmos KC, Tasker JG (2002) Neurosecretory and non-neurosecretory parvocellular neurons of the hypothalamic paraventricular nucleus express distinct electrophysiological properties. J Neuroendocrinol 14:929-932.
25. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
26. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
27. Murphy LL, Steger RW, Smith MS, Bartke A (1990) Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 52:316-321.
28. Murphy LL, Munoz RM, Adrian BA, Villanua MA (1998) Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 5:432-446.
29. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738.
30. Orchinik M, Murray TF, Moore FL (1991) A corticosteroid receptor in neuronal membranes. Science 252:1848-1851.
31. Orchinik M, Murray TF, Franklin PH, Moore FL (1992) Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci USA 89:3830-3834.
32. Puder M, Weidenfeld J, Chowers I, Nir I, Conforti N, Siegel RA (1982) Corticotrophin and corticosterone secretion following delta 1-tetrahydrocannabinol in intact and in hypothalamic deafferentated male rats. Exp Brain Res 46:85-88.
33. Rodriguez de Fonseca FR, Villanua MA, Munoz RM, Martin-Clark O, Navarro M (1995) Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats. Neuroendocrinology 61:714-721.
34. Rondeel JM, Heide R, de Greef WJ, van Toor H, van Haasteren GA, Klootwijk W, Visser TJ (1992) Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. Neuroendocrinology 56:348-353.
35. Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126:665-672.
36. Saphier D, Feldman S (1988) Iontophoretic application of glucocorticoids inhibits identified neurones in the rat paraventricular nucleus. Brain Res 453:183-190.
37. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
38. Surmeier DJ, Song WJ, Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
39. Suyemitsu T, Terayama H (1975) Specific binding sites for natural glucocorticoids in plasma membranes of rat liver. Endocrinology 96:1499-1508.
40. Swanson LW, Sawchenko PE (1980) Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31:410-417.
41. Tasker JG, Dudek FE (1991) Electrophysiological properties ofneurones in the region of the paraventricular nucleus in slices of rat hypothalamus. J Physiol (Lond) 434:271-293.
42. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592.
43. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462.
44. Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F (1999) Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 48:365-370.